Batch processes antibiotic fermentations

The batch and fed-batch procedures are used for most commercial antibiotic fermentations. A typical batch fermentor may hold over 150,000 Hters. When a maximum yield of antibiotic is obtained, the fermentation broth is processed by purification procedures tailored for the specific antibiotic being produced. Nonpolar antibiotics are usually purified by solvent extraction procedures water-soluble compounds are commonly purified by ion-exchange methods. Chromatography procedures can readily provide high quaHty material, but for economic reasons chromatography steps are avoided if possible. 

Antibiotics are produced by fermentation. The process may take a few days to obtain an extractable amount of product. Antibiotic production is done by the batch process. Oxygen transport is the major concern therefore sufficient polymeric sugar and protein with a trace amount of elemental growth factors are used to enhance production. An anti-biogram test is used to observe the amount of antimicrobial agent in the fermentation broth. A bioassay determines the activity unit of the bactericides. 

Most of fermentation and cell culture operations are done in the batch mode where a volume of sterile medium in a vessel is inoculated, the broth is fermented for a period, and the contents of the tank are removed and filtered. Semi-batch or fed-batch modes can also be used during large-scale production processes. Continuous fermentation, where sterile medium is continuously added to the fermentation system with a balancing withdrawal of broth for the extraction of the target molecule, has only been applied to a limited number of products such as those produced with yeast. Such limited application is due to difficulties of maintaining sterility for a long period. However, the implementation of continuous fermentation in the production of antibiotics, amino acids, and nucleic acids is anticipated soon. 

Despite the ever-increasing use of complex instrumentation, the application of feedback control techniques and the use of computers, the science of antibiotic fermentation is still imperfectly developed. Processes are difficult to optimize and no two apparently identical batches will ever be entirely the same. This is because living cell populations change both quantitatively and qualitatively throughout the production cycle and small changes in control parameters, such as a fluctuation in air pressure or a power dip, can potentially impact a batch and the effect may vary dependent upon the age of the batch. Also there tends to be significant batch to batch variation in the complex nutrients commonly used in the fermentations. 

For the most part, the antibiotic industry uses batch-type processes. The reason for this stems from the fact that most efficient antibiotic-producing organisms are highly mutated and are readily replaced by fastgrowing, less efficient antibiotic producers in a continuous culture. In order to avoid substrate repression or inhibition, some batch processes are continuously fed concentrated substrate on demand during the course of the batch cycle. This is referred to as a batch-fed fermentation. The production of bakers yeast is an example of a batch-fed process. In some highly mycelial antibiotic fermentation, 20 to 40 percent draw-off followed by fresh media makeup is practiced. In the trade, this is referred to as a repeated draw-off process. Strict continuous processes are practiced only in processes for the production of biomass for feed or food and the treatment of wastes. 

A full set of bioreactors with pH and temperature controllers are shown in Figure 1.3. The complete set of a 25 litre fermenter with all the accessory controlling units creates a good opportunity to control suitable production of biochemical products with variation of process parameters. Pumping fresh nutrients and operating in batch, fed batch and continuous mode are easy and suitable for producing fine chemicals, amino acids, and even antibiotics. 

All of the above processes are operated as batch fermentations, in which a volume of sterile medium in a vessel is inoculated. The broth is fermented for a defined period. The tank is then emptied and the products are separated to obtain the antibiotic. The vessel is then recharged for batch operation with medium and the sequence repeated, as often as required. Continuous fermentation is not common practice in the antibiotics industry. The antibiotic concentration will rarely exceed 20gT 1 and may be as low as 0.5g-l 1. 

A constant final concentration in the retentate loop can be maintained by bleeding out a small fraction, either out of the system or to some other location in the process. This operation is described as a batch feed and bleed and is commonly used in the processing of many high value biotechnology products such as batch fermentations to recover vitamins, enzymes and common antibiotics.The CFF system will require larger surface area since the system must be designed at the flux obtained at the final concentration factor (e.g., 20 for 95% recovery). 

A number of tests were also developed and further used routinely to detect other process-related impurities in clinical batches, such as a Limulus amoebocyte lysate test to quantify bacterial endotoxins (< 1 I.U./mg of BBG2Na) and a specific RP-HPLC assay to detect tetracycline (no trace detected) since this antibiotic was used for selection by drug pressure during the fermentation step. 

A large number of products In the pharmaceutical and food Industry Is obtained from fermentation processes. Examples are amino acids, stereoregular organic acids, antibiotics, ethanol, etc. In a classical fermentation process the product formation Is strictly coupled to cell growth resulting In a possibly unfavorable byproduction of biomass. Furthermore these processes are typically performed as batch operations. 

Biochemical Processing. Potential ELM applications in biochemical processing (44) include the separation of aminoacids (L-phenylalanine), biochemicals (acrylic and propionic acids), and antibiotics (penicillin G) from fermentation broths. A typical ELM system for the recovery of L>phenylalanine from fermentation broths is given in Table DC (45,46). The recovery from a broth containing 12-35 g/L of L-phenylalanine can be about 80% with a single batch extraction. Hong et al. (45) obtained a recovery of about 99% with four serial batch extractions in simulating their proposed continuous process with mixer-settler extractors. 

Example 7.1 Nonlinear Regression Using the Marquardt Method. In Prob. 5.5, we described the kinetics of a fermentation process that manufactures penicillin antibiotics. When the microorganism Penicillium chrysogenum is grown in a batch fermentor under carefully controlled conditions, the cells grow in a rate that can be modeled by the logistic law... 

---